Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
We identified an autosomal recessive infantile-onset symptomatic epilepsy syndrome associated with developmental stagnation and blindness. Assuming a founder effect in a large Old Order Amish pedigree, we carried out a genome-wide screen for linkage and identified a single region of homozygosity on chromosome 2p12-p11.2 spanning 5.1 cM (maximum lod score of 6.84). We sequenced genes in the region and identified a nonsense mutation in SIAT9, which is predicted to result in the premature termination of the GM3 synthase enzyme (also called lactosylceramide alpha-2,3 sialyltransferase). GM3 synthase is a member of the sialyltransferase family and catalyzes the initial step in the biosynthesis of most complex gangliosides from lactosylceramide. Biochemical analysis of plasma glycosphingolipids confirmed that affected individuals lack GM3 synthase activity, as marked by a complete lack of GM3 ganglioside and its biosynthetic derivatives and an increase in lactosylceramide and its alternative derivatives. Although the relationship between defects in ganglioside catabolism and a range of lysosomal storage diseases is well documented, this is the first report, to our knowledge, of a disruption of ganglioside biosynthesis associated with human disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Munro, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00882-1 · Cited by 1,514
Enhanced insulin sensitivity in mice lacking ganglioside GM3
Yamashita, T., Hashiramoto, A., Haluzik, M., Mizukami, H., Beck, S., Norton, A., Kono, M., Tsuji, S., Daniotti, J. L., Werth, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0635898100 · Cited by 531
Mice Expressing Only Monosialoganglioside GM3 Exhibit Lethal Audiogenic Seizures
Kawai, H., Allende, M. L., Wada, R., Kono, M., Sango, K., Deng, C., Miyakawa, T., Crawley, J. N., Werth, N., Bierfreund, U., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000847200 · Cited by 227
Gangliosides as modulators of cell function
Zeller, C. B., & Marchase, R. B. (1992) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1992.262.6.c1341 · Cited by 208
Biosynthesis and degradation of mammalian glycosphingolipids
Sandhoff, K., & Kolter, T. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1265 · Cited by 183
Neville, D. C. A., Coquard, V., Priestman, D. A., te Vruchte, D. J. M., Sillence, D. J., Dwek, R. A., Platt, F. M., & Butters, T. D. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.03.051 · Cited by 178
Self-citationTraveling for the glycosphingolipid path
Hakomori, S.-I. (2000) · Glycoconjugate Journal · doi:10.1023/a:1011086929064 · Cited by 178
Wraith, J. E. (2002) · Seminars in Neonatology · doi:10.1053/siny.2001.0088 · Cited by 166
Refractory Skin Injury in Complex Knock-out Mice Expressing Only the GM3 Ganglioside
Inoue, M., Fujii, Y., Furukawa, K., Okada, M., Okumura, K., Hayakawa, T., Furukawa, K., & Sugiura, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201631200 · Cited by 107
Glycosphingolipid functions: insights from engineered mouse models
Proia, R. L. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1268 · Cited by 84
Cited by
Glycosylation in Cellular Mechanisms of Health and Disease
Ohtsubo, K., & Marth, J. D. (2006) · Cell · doi:10.1016/j.cell.2006.08.019 · Cited by 2,788
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“phenotypes (405, 406), humans with similar defects suffer from severe multisystem disease (407, 408).”
BackgroundSialic acids in human health and disease
Varki, A. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.06.002 · Cited by 999
Sphingolipid and Glycosphingolipid Metabolic Pathways in the Era of Sphingolipidomics
Merrill, A. H. (2011) · Chemical Reviews · doi:10.1021/cr2002917 · Cited by 785
Schnaar, R. L., Gerardy-Schahn, R., & Hildebrandt, H. (2014) · Physiological Reviews · doi:10.1152/physrev.00033.2013 · Cited by 745
Metadata
- Authors
- Simpson, M. A., Cross, H., Proukakis, C., Priestman, D. A., Neville, D. C. A., Reinkensmeier, G., Wang, H., Wiznitzer, M., Gurtz, K., Verganelaki, A., Pryde, A., Patton, M. A., Dwek, R. A., Butters, T. D., Platt, F. M., & Crosby, A. H.
- Affiliations
- University of London (GB)
- University of Arizona (US)
- University of Oxford (GB)
- Rainbow Babies & Children's Hospital (US)
- Corresponding author
- Crosby, Andrew H
- ORCID
- Venue
- Nature Genetics
- Published
- 2004-10-24
- Volume
- 36
- Issue
- 11
- Pages
- 1225-1229
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2161292836
- Cited by
- 389
- References
- 22
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 17 · 2023: 20 · 2022: 25 · 2021: 18 · 2020: 25 · 2019: 15 · 2018: 29 · 2017: 11 · 2016: 19 · 2015: 16 · 2014: 27 · 2013: 19 · 2012: 18
- FWCI
- 8.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Research to Prevent Blindness
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- GM3 synthase, loss-of-function mutations, autosomal recessive inheritance, founder effect, Old Order Amish, ganglioside biosynthesis, GM3 ganglioside, lactosylceramide, glycosphingolipids, blindness, sialyltransferase, linkage mapping
- MeSH terms
- Blindness, Developmental Disabilities, Chromosomes, Human, Pair 2, Epilepsy, Female, G(M3) Ganglioside, Genes, Recessive, Glycosphingolipids, Humans, Infant, Infant, Newborn, Male, Pedigree, Sialyltransferases, Syndrome, Codon, Nonsense, Founder Effect
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.